PlatformSTL
PlatformSTL is a St. Louis-based healthcare software consulting firm that translates academic research into clinical tools. Its portfolio spans AI-powered products for transplant typing (Athlon2), kidney biopsy assessment (Trusted Kidney), pediatric handwriting evaluation (STEGA), and ADL monitoring (Proprio).
- Company typePrivate
- Founded-
- HeadquartersSt Louis, United States
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What PlatformSTL does
PlatformSTL is a St. Louis-based healthcare software consulting and product development firm, operating under the legal entity NEWVENTUREIQ, LLC. The company translates academic research into market-ready clinical software tools, serving healthcare innovators that include academic researchers, clinical inventors, and specialty care institutions. PlatformSTL maintains a deeply embedded relationship with Washington University in St. Louis and is housed in BioGenerator Labs within the Cortex Innovation Community, one block from the WashU School of Medicine. Its core operating team consists of three members — CEO and Founder Victoria Swamidass, UX lead Mike Blackford, and Engineering Architect Kevin Boehm — supported by an extended bench of consulting software engineers. The company also runs a software consulting practice providing product development, UX design, and engineering services for early-stage healthcare technologies, with custom engagement-based pricing.
The company has developed a portfolio of five clinical software products spanning transplant medicine, pathology, rehabilitation, and pediatric occupational therapy. Athlon2 is a commercialized bioinformatics pipeline for high-resolution, ambiguity-free HLA tissue typing using Oxford Nanopore sequencing, achieving 99.5% concordance with reference methods. Trusted Kidney applies machine learning to quantify donor kidney biopsies with the goal of increasing successful transplant rates. Proprio is an AI-powered wearable platform that detects activities of daily living with 88% accuracy across seven tasks and was validated in 11 community-dwelling stroke survivors. STEGA is an iPad-based handwriting assessment app using Apple Pencil with automated objective scoring, validated in a study of 54 children. Write to Hand is an additional handwriting motor-skills app demonstrated at the STL Startup Connection event.
PlatformSTL's revenue model is hybrid. Professional services revenue from software consulting engagements forms the primary stream, supplemented by software licensing for Athlon2 and subscription-style offerings for clinical software products including Trusted Kidney, STEGA, and Proprio. Pricing is not publicly disclosed. Go-to-market is sales-led through direct consultation engagement with inventors, businesses, and academic institutions, supplemented by event presence (STL Startup Connection) and academic partnership referrals. R&D and early product development have been funded through a 2018 NIH STTR grant for STEGA and a 2018 HHS Phase I SBIR grant through NIDILRR for Proprio; no traditional equity funding rounds were identified in the available data. The company serves a primarily domestic US market, anchored in Missouri with national reach.
PlatformSTL firmographics
Firmographics- Name
- PlatformSTL
- Legal name
- NEWVENTUREIQ, LLC
- Website
- https://platformstl.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- PlatformSTL is a St. Louis-based healthcare software consulting firm that translates academic research into clinical tools. Its portfolio spans AI-powered products for transplant typing (Athlon2), kidney biopsy assessment (Trusted Kidney), pediatric handwriting evaluation (STEGA), and ADL monitoring (Proprio).
- Ownership category
- akta.pro rank
PlatformSTL industry classification
Industry- Product category
- Healthcare Software
- NAICS
- Custom Computer Programming Services (541511), Other Scientific and Technical Consulting Services (54169), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Computer Programming Services (7371), Services-Medical Laboratories (8071)
- akta.pro primary industry
- Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)
- akta.pro secondary industries
- Biostatistics, Statistical Computing & Clinical Programming (SAS/R/Pipelines) (HLACAOAO), Medical & Clinical Reference (Physicians, Nursing, Allied Health) (EDAGAGAA)
Keywords
Where PlatformSTL is headquartered
LocationHeadquarters
- HQ city
- St Louis
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
PlatformSTL business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales
Revenue model
- Software Consulting Services: Provides software consulting, product development, UX design, and engineering for early-stage healthcare technologies. Services include brainstorming, initial prototype development, business management and strategy, pre-funding support, and commercial-grade product development.
- Software Licensing (Athlon2): Commercial software licensing for Athlon2 bioinformatics pipeline for transplant labs using Oxford Nanopore sequencing platform.
- Clinical Software Products: Direct software products for clinicians including Trusted Kidney (pathologists), STEGA (occupational therapists), Athlon2 (transplant labs), and Proprio (rehabilitation providers).
Go-to-market motion2 records
Distribution channels1 record
Marketing channels3 records
PlatformSTL product offering
Product offeringCore offering
PlatformSTL develops clinical software tools that translate academic research into healthcare practice. Its product portfolio includes Athlon2 (HLA tissue typing for transplant labs using Oxford Nanopore sequencing), STEGA (iPad handwriting assessment app for occupational therapists), Trusted Kidney (ML software for pathologist kidney biopsy quantification), and Proprio (AI-powered wearable platform that measures activities of daily living for rehabilitation providers). The company also provides software consulting, product development, UX design, and engineering services to healthcare inventors, entrepreneurs, and academic institutions.
Product overview
PlatformSTL is a St. Louis-based healthcare technology company that develops software tools translating emerging science into clinical practice. The company offers a portfolio of clinical tools: STEGA (iPad app for handwriting assessment for occupational therapists), Trusted Kidney (ML software for assessing donor kidney biopsies for pathologists), Athlon2 (software for rapid, high-resolution tissue typing for transplant labs), Proprio (AI-powered wearable platform for tracking activities of daily living for rehabilitation providers), and Write to Hand (handwriting motor skills assessment app). The company also provides software consulting services for early-stage healthcare technologies.
Differentiator
Problem solved
Functional benefit
Brands
- STEGA: The first digital test of handwriting - an iPad app using Apple Pencil to assess handwriting skills in children, helping schools identify kids who need occupational therapy support.
- Proprio
- Trusted Kidney
- Athlon2
Products and services
- Athlon2 First-in-industry software that enables rapid, high-resolution tissue typing using Oxford Nanopore sequencing. Consists of a bioinformatics pipeline and a cloud-based tool that delivers ambiguity-free HLA typing results for transplant decision-making. Targets transplant labs and Barnes-Jewish Hospital HLA Laboratory collaborators.
- STEGA The first digital test of handwriting, an iPad app using Apple Pencil that assesses fine-motor skills in children through shape-based exercises. Provides objective, automatic scoring for occupational therapists to identify fine-motor delays, with telehealth compatibility.
- Trusted Kidney Imaging software that improves biopsy accuracy through rapid, automated quantification. Uses machine learning to assess donor kidney biopsies for pathologists, with the goal of increasing successful transplant rates.
- Proprio AI platform that uses wearables to accurately measure and report activities of daily living (ADLs) in home environments. Provides valuable insights for physicians and rehabilitation providers about how patients and elders spend time at home, with 88% accuracy detecting seven tasks in independent testing.
- Write to Hand App to assess handwriting motor skills, demonstrated at the Startup Connection event.
- Software Consulting Services Software consulting, product development, UX design, and engineering for early-stage healthcare technologies. Services include brainstorming, initial prototype development, business management and strategy, pre-funding support, and commercial-grade product development.
Quantifiable outcome
- 88% accuracy in detecting 7 activities of daily living tasks
- +2 more outcomes
Companies that use PlatformSTL
Customer profileNamed customers2 records
Segments6 records
Ideal customer profiles5 records
PlatformSTL technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature4 records
PlatformSTL partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered minor and core.
- Husch BlackwellminorSelected PlatformSTL as firm's winner for legal services at STL Startup Connection event, providing pro bono or discounted legal support for startup.
- Washington University in St. LouiscorePrimary research and development partner for multiple PlatformSTL technologies. Collaboration includes HLA typing software (Athlon) with Dr. Chang Liu, Proprio wearable/AI system with Dr. Pin-Wei Chen, STEGA handwriting assessment with Dr. Benjamin Philip, and Trusted Kidney ML software. Washington University provides scientific leadership and clinical validation for products.
- Oxford Nanopore TechnologiescoreTechnology provider for MinION device enabling portable, single-molecule sequencing with ultra-long reads. PlatformSTL's Athlon software enables HLA typing applications using this sequencing platform.
Scale indicators7 records
Recent moves7 records
Expansion highlights5 records
PlatformSTL competitors and assessment
Company assessmentDirect peers
- Force Therapeutics: Digital care platform for musculoskeletal and post-stroke rehabilitation, combining remote monitoring with clinician dashboards. Directly comparable to Proprio because both target rehabilitation providers and use wearable/activity data to track home-based recovery and ADLs.
- DNAnexus: Cloud-based bioinformatics and genomic data platform serving clinical and translational researchers. Directly comparable to PlatformSTL's Athlon2 because both package complex genomic/bioinformatics pipelines (e.g., HLA typing, NGS analysis) into managed software for clinical and research users.
- HistoIndex: Digital pathology AI platform for biopsy quantification, especially in liver and kidney tissue. Closely comparable to Trusted Kidney because both apply machine learning to pathology imaging to deliver automated, quantitative biopsy assessment for transplant decision-making.
- Constant Therapy Health: Digital therapeutics platform for cognitive, speech, and occupational therapy, including pediatric and stroke rehabilitation. Comparable to STEGA and Proprio as clinically validated digital tools for occupational therapists and rehabilitation providers.
- Fabric Genomics: Clinical genomics interpretation platform used by hospitals and reference labs for hereditary disease and transplant/HLA-related workflows. Comparable to Athlon2 as a software layer that turns genomic sequencing data into clinical decision support for transplant and pathology use cases.
Emerging players
- Xealth: Digital health prescribing and clinical workflow platform that helps health systems deploy and monitor digital health tools. Adjacent to PlatformSTL's clinical tool portfolio in enabling clinician workflow integration of third-party digital health applications.
Others
- BioGenerator: St. Louis-based accelerator and investor that houses PlatformSTL and supports WashU spinouts. Not a direct competitor but the closest ecosystem peer — comparable because they co-invest in and incubate healthcare software startups with academic origins, sharing the same WashU/BioSTL pipeline.
- Sling Health: WashU-affiliated healthcare innovation incubator from which PlatformSTL's Proprio co-inventor Dr. Pin-Wei Chen came. Comparable as a translational academic-to-startup pipeline producing early-stage healthcare software ventures from the same WashU research base.
Broad incumbents
- Caregility: Established telehealth/virtual care platform serving large hospital systems. Comparable as a broader incumbent offering clinician-facing software that overlaps with PlatformSTL's clinical-decision-support and remote-monitoring positioning, particularly around telehealth-compatible assessments like STEGA.
- QlikTech (Qlik) Health Cloud / Arcadia: Healthcare data and analytics platforms serving health systems and ACOs. Relevant incumbent peer because clinical decision support and population-level analytics increasingly overlap with the AI/bioinformatics work PlatformSTL is doing for transplant and pathology use cases.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat4 records
Key risks7 records
Key highlights6 records
Customer concentration
PlatformSTL social profiles
Digital presencePlatformSTL financial estimates
Financial estimateRevenue estimate
Valuation estimate
PlatformSTL leadership team
Management profileNumber of profiles
Profiles5 records
PlatformSTL funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
PlatformSTL M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about PlatformSTL
What does PlatformSTL do?
PlatformSTL develops clinical software tools that translate academic research into healthcare practice. Its product portfolio includes Athlon2 (HLA tissue typing for transplant labs using Oxford Nanopore sequencing), STEGA (iPad handwriting assessment app for occupational therapists), Trusted Kidney (ML software for pathologist kidney biopsy quantification), and Proprio (AI-powered wearable platform that measures activities of daily living for rehabilitation providers). The company also provides software consulting, product development, UX design, and engineering services to healthcare inventors, entrepreneurs, and academic institutions.
Is PlatformSTL a public or private company?
PlatformSTL is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was PlatformSTL founded?
PlatformSTL was founded in -1. It employs 1 to 10 people.
Where is PlatformSTL based?
PlatformSTL is headquartered in St Louis, United States, in the North America region.
How does PlatformSTL make money?
Three revenue lines are on record. Software Consulting Services are the primary driver. The others are software Licensing (Athlon2) and clinical Software Products.
Who are PlatformSTL's main competitors?
Direct peers on record are Force Therapeutics, DNAnexus, HistoIndex, Constant Therapy Health and Fabric Genomics. Xealth is listed as an emerging player. Others are BioGenerator and Sling Health. Broad incumbents are Caregility and QlikTech (Qlik) Health Cloud / Arcadia.
Does PlatformSTL have an API?
No public API is recorded for PlatformSTL.
What industry is PlatformSTL in?
PlatformSTL's product category is Healthcare Software. Its primary akta.pro industry code is HLAGAJAM, Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF), with a secondary code of HLACAOAO, Biostatistics, Statistical Computing & Clinical Programming (SAS/R/Pipelines). Its NAICS code is 541511 and its SIC code is 8731.